Recent Advances in Inflammation & Allergy Drug Discovery publishes full-length/mini-reviews, research articles, letters, case reports, perspectives, systematic reviews, and thematic issues in the field of inflammation and allergy research, including new strategies in diagnosis, treatment, and prevention of allergic and inflammatory diseases, gastrointestinal allergy, inflammation and immune dysfunction, liver allergy, inflammation and immune disorders. The journal covers all pharmacological aspects of inflammation and allergy, including mediators of inflammation and allergy, as well as cellular processes, cytotoxicity, cell biology, and molecular mechanisms involved in the production of inflammatory and hypersensitivity reactions, . Topics related to the effect of dietary intake of protein, carbohydrates and fatty acids are also included.
The journal encourages submission of articles on anti-inflammatory and anti-allergy therapies, acute and chronic inflammation, allergic and immunologic diseases, chronic obstructive pulmonary disease (COPD) allied inflammation, irritant induced asthma, respiratory aids, clinical immunology, primary immune deficiencies, immune response, and regulation, allergic rhinitis, drug allergies, atopic dermatitis, pathogenesis and interaction of pathogen and host immunity, allergy associated skin test and their interpretation, tissue damage, occupational and environmental allergy, allergen immunotherapy.
Articles on important and recent patents in the field are also included in the journal. The journal is a must-read for all the researchers involved in inflammation and allergy drug design and discovery.